← Leaderboards
Carol Ann Lange
University Of Minnesota
$17,870,830
Attributed
$20,561,006
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,561,006 · 13
By mechanism
R01$12,777,533 · 7
T32$7,016,119 · 1
R21$591,001 · 2
P30$166,853 · 1
R13$9,500 · 2
Top collaborators
- Julie H Ostrander5 shared
- Carol Ann Sartorius5 shared
- Scott M. Dehm1 shared
- Jill M Siegfried1 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Rachel R Hardeman$3,148,680
- Michele L Allen$11,384,036
- David H Ingbar$22,490,578
- Kelsey Elizabeth Johnson$1,040,824
- Catherine M Jordan$326,968
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionResistanceMediatingMammary NeoplasmsGrowth FactorPhosphorylationMalignant Breast NeoplasmBreast Cancer CellResponseSignal PathwayPathway InteractionsEventCellsGrowth Factor ReceptorsGrowthCell ProliferationIn VivoReceptor SignalingLigandsRegulationSteroid Hormone ReceptorPhosphotransferasesProgesteroneProtein Kinase
Grant awards (62)
Shared Resource Management$98,425
P30 · FY2025 · CA · contact PI
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer$571,826
R01 · FY2024 · CA · contact PI
Molecular, Genetic and Cellular Targets of Cancer Training Program$551,364
T32 · FY2024 · CA · contact PI
SRC-3/PELP1 complexes drive stem-like phenotypes in luminal breast cancer$465,438
R01 · FY2024 · CA · contact PI
Shared Resource Management$68,428
P30 · FY2024 · CA · contact PI
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer$589,881
R01 · FY2023 · CA · contact PI
Molecular, Genetic and Cellular Targets of Cancer Training Program$480,502
T32 · FY2023 · CA · contact PI
SRC-3/PELP1 complexes drive stem-like phenotypes in luminal breast cancer$480,136
R01 · FY2023 · CA · contact PI
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer$589,881
R01 · FY2022 · CA · contact PI
Molecular, Genetic and Cellular Targets of Cancer Training Program$483,658
T32 · FY2022 · CA · contact PI
SRC-3/PELP1 complexes drive stem-like phenotypes in luminal breast cancer$480,136
R01 · FY2022 · CA · contact PI
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer$597,064
R01 · FY2021 · CA · contact PI
Molecular, Genetic and Cellular Targets of Cancer Training Program$580,396
T32 · FY2021 · CA · contact PI
SRC-3/PELP1 complexes drive stem-like phenotypes in luminal breast cancer$488,236
R01 · FY2021 · CA · contact PI
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer$610,563
R01 · FY2020 · CA · contact PI
Molecular, Genetic and Cellular Targets of Cancer Training Program$591,896
T32 · FY2020 · CA · contact PI
SRC-3/PELP1 complexes drive stem-like phenotypes in luminal breast cancer$500,524
R01 · FY2020 · CA · contact PI
Cancer Biology Training Grant$524,566
T32 · FY2019 · CA · contact PI
Inducible PTK6 expression drives oncogenic signaling in breast cancer$431,610
R01 · FY2019 · CA · contact PI
Cancer Biology Training Grant$473,065
T32 · FY2018 · CA · contact PI
Inducible PTK6 expression drives oncogenic signaling in breast cancer$442,155
R01 · FY2018 · CA · contact PI
8th Great Lakes Nuclear Receptors Conference (GLNRC)$5,000
R13 · FY2018 · CA
Inducible PTK6 expression drives oncogenic signaling in breast cancer$444,960
R01 · FY2017 · CA · contact PI
Cancer Biology Training Grant$416,373
T32 · FY2017 · CA · contact PI
Cancer Biology Training Grant$5,161
T32 · FY2017 · CA · contact PI
FASEB SRC on FASEB SRC on Rapid Signaling and Genomic Steroid Hormone Actions in Health & Disease$4,500
R13 · FY2017 · CA · contact PI
Cancer Biology Training Grant$505,623
T32 · FY2016 · CA · contact PI
Inducible PTK6 expression drives oncogenic signaling in breast cancer$432,155
R01 · FY2016 · CA · contact PI
Role of Phospho-Progesterone Receptors (PR) in Hormone Refractory Breast Cancer$366,653
R01 · FY2016 · CA · contact PI
Cancer Biology Training Grant$447,500
T32 · FY2015 · CA · contact PI
Inducible PTK6 expression drives oncogenic signaling in breast cancer$445,155
R01 · FY2015 · CA · contact PI
Role of Phospho-Progesterone Receptors (PR) in Hormone Refractory Breast Cancer$366,653
R01 · FY2015 · CA · contact PI
Cancer Biology Training$450,920
T32 · FY2014 · CA · contact PI
Role of Phospho-Progesterone Receptors (PR) in Hormone Refractory Breast Cancer$355,653
R01 · FY2014 · CA · contact PI
Cancer Biology Training$394,917
T32 · FY2013 · CA · contact PI
Role of Phospho-Progesterone Receptors (PR) in Hormone Refractory Breast Cancer$351,879
R01 · FY2013 · CA · contact PI
Role of Phospho-Progesterone Receptors (PR) in Hormone Refractory Breast Cancer$50,000
R01 · FY2013 · CA · contact PI
Role of Phospho-Progesterone Receptors (PR) in Hormone Refractory Breast Cancer$366,654
R01 · FY2012 · CA · contact PI
Cancer Biology Training$359,786
T32 · FY2012 · CA · contact PI
Cancer Biology Training$312,030
T32 · FY2011 · CA · contact PI
Brk Signals to ERK5 in Breast Cancer$241,728
R01 · FY2011 · CA · contact PI
Cancer Biology Training$35,287
T32 · FY2011 · CA · contact PI
Cancer Biology Training$403,075
T32 · FY2010 · CA · contact PI
Brk Signals to ERK5 in Breast Cancer$249,257
R01 · FY2010 · CA · contact PI
Progestin and growth factor cross-talk in breast cancer$213,392
R01 · FY2010 · CA · contact PI
Brk Signals to ERK5 in Breast Cancer$47,822
R01 · FY2010 · CA · contact PI
Brk Signals to ERK5 in Breast Cancer$249,308
R01 · FY2009 · CA · contact PI
Progestin and growth factor cross-talk in breast cancer$213,392
R01 · FY2009 · CA · contact PI
Brk Signals to ERK5 in Breast Cancer$249,357
R01 · FY2008 · CA · contact PI
Progestin and growth factor cross-talk in breast cancer$213,366
R01 · FY2008 · CA · contact PI
Brk signal transduction in breast cancer$249,405
R01 · FY2007 · CA · contact PI
Progestin and growth factor cross-talk in breast cancer$228,392
R01 · FY2007 · CA · contact PI
MAPKs Regulate Progesterone Receptors by SUMO Modulation$132,243
R21 · FY2007 · CA · contact PI
Progestin and growth factor cross-talk in breast cancer$219,765
R01 · FY2006 · CA · contact PI
MAPKs Regulate Progesterone Receptors by SUMO Modulation$161,758
R21 · FY2006 · CA · contact PI
Progestin and Growth Factor Cross-talk in Breast Cancer$222,750
R01 · FY2004 · DK
Progestin and Growth Factor Cross-talk in Breast Cancer$222,750
R01 · FY2003 · DK
Progestin and Growth Factor Cross-talk in Breast Cancer$222,750
R01 · FY2002 · DK
PROGESTIN AND GROWTH FACTOR CROSS-TALK IN BREAST CANCER$155,674
R01 · FY2001 · DK
HORMONAL REGULATION OF BREAST TUMOR KINASE$148,500
R21 · FY2001 · DK
PROGESTIN AND GROWTH FACTOR CROSS-TALK IN BREAST CANCER$151,213
R01 · FY2000 · DK
HORMONAL REGULATION OF BREAST TUMOR KINASE$148,500
R21 · FY2000 · DK